Interstitial pneumonia belongs to a group of diseases in which pulmonary fibrosis is a manifestation of lung imaging. Interstitial pneumonia can develop into pulmonary fibrosis. Clinically, it is necessary to find the etiology of interstitial pneumonia and pulmonary fibrosis to guide treatment.
1. Interstitial pneumonia belongs to a group of diseases, and pulmonary fibrosis is a pulmonary imaging manifestation. Patients with interstitial pneumonia, if left untreated, will develop pulmonary fibrosis when the disease reaches the end stage, so they are not the same.
2. For interstitial pneumonia secondary to rheumatic immune disease, oral glucocorticoids such as prednisone acetate, combined with immunosuppressants such as cyclophosphamide tablets and azathioprine can be considered. For idiopathic interstitial pneumonia, oral antifibrotic drugs such as pirfenidone and nidaneb acetate are given. For interstitial pneumonias caused by pathogenic infections such as viruses, symptomatic antiviral agents such as ribavirin should be used in combination with oxygen therapy.
3. End-stage interstitial pneumonia, often severe pulmonary fibrosis, need to take lung metastasis to prolong survival.
Patients with interstitial pneumonia and pulmonary fibrosis should seek medical attention in a timely manner and follow the doctor’s instructions.